[1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation 2013;127:e6-e245.]Search in Google Scholar
[2. Wilke T, Groth A, Mueller S, Pfannkuche M, Verheyen F, Linder R, et al. Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. Europace. 2013;15:486-93.10.1093/europace/eus33323220354]Search in Google Scholar
[3. Liew A, Eikelboom JW, O’Donnell M, Hart RG. Assessment of Anticoagulation Intensity and Management of Bleeding With Old and New Oral Anticoagulants. Can J Cardiol. 2013;29:S34-44.10.1016/j.cjca.2013.04.01323790596]Search in Google Scholar
[4. Pernod G, Albaladejo P, Godier A, Samama CM, Susen S, Gruel Y, et al. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP). Arch Cardiovasc Dis. 2013;106:382-93.10.1016/j.acvd.2013.04.00923810130]Search in Google Scholar
[5. Kozek-Langenecker SA, Afshari A, Albaladejo P, Santullano CA, De Robertis E, Filipescu DC, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2013;30:270-382.10.1097/EJA.0b013e32835f4d5b23656742]Search in Google Scholar
[6. Favaloro EJ, Lippi G, Koutts J. Laboratory testing of anticoagulants: the present and the future. Pathology. 2011;43:682-92.10.1097/PAT.0b013e32834bf5f422081129]Search in Google Scholar
[7. Blasi A, Muñoz G, de Soto I, Mellado R, Taura P, Rios J, et al. Reliability of thromboelastometry for detecting the safe coagulation threshold in patients taking acenocoumarol after elective heart valve replacement. Thromb Res. 2015;136:669-72.10.1016/j.thromres.2015.07.00326232350]Search in Google Scholar
[8. Yao Y, Zhang JH, Tang XF, He C, Ma YL, Xu JJ, et al. Head to Head Comparison of Two Point-of-care Platelet Function Tests Used for Assessment of On-clopidogrel Platelet Reactivity in Chinese Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention. Chin Med J 2016;129:2269-74.10.4103/0366-6999.190664504001027647183]Search in Google Scholar
[9. Sarode R, Milling TJ Jr, Refaai MA, Mangione A, Schneider A, Durn BL, et al. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. Circulation. 2013;128:1234-43.10.1161/CIRCULATIONAHA.113.002283670118123935011]Search in Google Scholar
[10. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18:1609-1678.10.1093/europace/euw29527567465]Search in Google Scholar
[11. Hawn MT, Graham LA, Richman JS, Itani KM, Henderson WG, Maddox TM. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. JAMA. 2013;310:1462-72.10.1001/jama.2013.27878724101118]Search in Google Scholar